{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:51:52Z","timestamp":1793047912720,"version":"4.5.0"},"reference-count":54,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Integration of human papillomavirus (HPV) DNA into the host genome is a frequent event in cervical carcinogenesis and is reported to occur at randomly selected chromosomal sites. However, as the databases are being up-dated continuously, the knowledge based on sequenced viral integration sites also expands. In this study, viral-cellular fusion transcripts of a preselected group of 74 cervical carcinoma or cervical intraepithelial neoplasia grade 3 (CIN3) biopsies harboring integrated HPV16, HPV18, HPV31, HPV33, or HPV45 DNA were amplified by 3\u2032-rapid amplification of cDNA ends PCR and sequenced. Consistent with previous reports, integration sites were found to be distributed throughout the genome. However, 23% (17 of 74) of the integration sites were located within the cytogenetic bands 4q13.3, 8q24.21, 13q22.1, and 17q21, in clusters ranging from 86 to 900 kb. Of note is that clusters 8q24.21 and 13q22.1 are within 1.5 Mbp of an adjacent fragile site whereas clusters 4q13.3 and 17q21 are &amp;gt;15 Mbp distant to any known fragile sites. It is tempting to speculate that as yet unknown fragile sites may be identified on the basis of HPV integration hotspots. No correlation between HPV type and specific integration loci was found. Of 74 fusion transcripts, 28 contained cellular sequences, which were homologous to known genes, and 40 samples contained sequences of predicted genes. In 33 fusion transcripts, both viral and cellular sequences were in sense orientation, indicating that the gene itself or upstream sequences were affected by integration. These data suggest that the influence of HPV integration on host gene expression may not be a rare effect and should encourage more detailed analyses. [Cancer Res 2008;68(7):2514\u201322]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-2776","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T19:44:16Z","timestamp":1207079056000},"page":"2514-2522","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["The Majority of Viral-Cellular Fusion Transcripts in Cervical Carcinomas Cotranscribe Cellular Sequences of Known or Predicted Genes"],"prefix":"10.1158","volume":"68","author":[{"given":"Irene","family":"Kraus","sequence":"first","affiliation":[{"name":"1Institute of Pathology, Rikshospitalet University Hospital;"},{"name":"3NorChip AS, Klokkarstua, Norway;"},{"name":"4Gyna\u0308kologische Molekularbiologie, Frauenklinik der Friedrich-Schiller-Universita\u0308t, Jena, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Driesch","sequence":"additional","affiliation":[{"name":"4Gyna\u0308kologische Molekularbiologie, Frauenklinik der Friedrich-Schiller-Universita\u0308t, Jena, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Vinokurova","sequence":"additional","affiliation":[{"name":"5Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Hovig","sequence":"additional","affiliation":[{"name":"2Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Schneider","sequence":"additional","affiliation":[{"name":"6Frauenklinik mit Hochschulambulanz der Charite\u0301, Campus Benjamin Franklin und Campus Mitte, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"von Knebel Doeberitz","sequence":"additional","affiliation":[{"name":"5Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Du\u0308rst","sequence":"additional","affiliation":[{"name":"4Gyna\u0308kologische Molekularbiologie, Frauenklinik der Friedrich-Schiller-Universita\u0308t, Jena, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"2022061700304227500_B1","doi-asserted-by":"crossref","unstructured":"Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet\u20081999; 354: 20\u20135.","DOI":"10.1016\/S0140-6736(98)12490-X"},{"key":"2022061700304227500_B2","doi-asserted-by":"crossref","unstructured":"Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer\u20081995; 61: 306\u201311.","DOI":"10.1002\/ijc.2910610305"},{"key":"2022061700304227500_B3","doi-asserted-by":"crossref","unstructured":"Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med\u20082003; 348: 518\u201327.","DOI":"10.1056\/NEJMoa021641"},{"key":"2022061700304227500_B4","doi-asserted-by":"crossref","unstructured":"Kraus I, Molden T, Holm R, et al. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J Clin Microbiol\u20082006; 44: 1310\u20137.","DOI":"10.1128\/JCM.44.4.1310-1317.2006"},{"key":"2022061700304227500_B5","doi-asserted-by":"crossref","unstructured":"zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst\u20082000; 92: 690\u20138.","DOI":"10.1093\/jnci\/92.9.690"},{"key":"2022061700304227500_B6","doi-asserted-by":"crossref","unstructured":"Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene\u20082001; 20: 7874\u201387.","DOI":"10.1038\/sj.onc.1204869"},{"key":"2022061700304227500_B7","doi-asserted-by":"crossref","unstructured":"Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res\u20082002; 89: 213\u201328.","DOI":"10.1016\/S0168-1702(02)00190-9"},{"key":"2022061700304227500_B8","doi-asserted-by":"crossref","unstructured":"Duensing S, Lee LY, Duensing A, et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci U S A\u20082000; 97: 10002\u20137.","DOI":"10.1073\/pnas.170093297"},{"key":"2022061700304227500_B9","doi-asserted-by":"crossref","unstructured":"Munger K, Hayakawa H, Nguyen CL, Melquiot NV, Duensing A, Duensing S. Viral carcinogenesis and genomic instability. EXS\u20082006; (96): 179\u201399.","DOI":"10.1007\/3-7643-7378-4_8"},{"key":"2022061700304227500_B10","doi-asserted-by":"crossref","unstructured":"Du\u0308rst M, Kleinheinz A, Hotz M, Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol\u20081985; 66: 1515\u201322.","DOI":"10.1099\/0022-1317-66-7-1515"},{"key":"2022061700304227500_B11","doi-asserted-by":"crossref","unstructured":"Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res\u20082004; 64: 3878\u201384.","DOI":"10.1158\/0008-5472.CAN-04-0009"},{"key":"2022061700304227500_B12","doi-asserted-by":"crossref","unstructured":"Pett MR, Alazawi WO, Roberts I, et al. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res\u20082004; 64: 1359\u201368.","DOI":"10.1158\/0008-5472.CAN-03-3214"},{"key":"2022061700304227500_B13","doi-asserted-by":"crossref","unstructured":"Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol\u20081995; 69: 2989\u201397.","DOI":"10.1128\/jvi.69.5.2989-2997.1995"},{"key":"2022061700304227500_B14","doi-asserted-by":"crossref","unstructured":"Romanczuk H, Howley PM. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A\u20081992; 89: 3159\u201363.","DOI":"10.1073\/pnas.89.7.3159"},{"key":"2022061700304227500_B15","doi-asserted-by":"crossref","unstructured":"Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol\u20082006; 44: 1755\u201362.","DOI":"10.1128\/JCM.44.5.1755-1762.2006"},{"key":"2022061700304227500_B16","doi-asserted-by":"crossref","unstructured":"von Knebel Doeberitz M, Bauknecht T, Bartsch D, zur Hausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A\u20081991; 88: 1411\u20135.","DOI":"10.1073\/pnas.88.4.1411"},{"key":"2022061700304227500_B17","doi-asserted-by":"crossref","unstructured":"Du\u0308rst M, Bosch FX, Glitz D, Schneider A, zur HH. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol\u20081991; 65: 796\u2013804.","DOI":"10.1128\/jvi.65.2.796-804.1991"},{"key":"2022061700304227500_B18","doi-asserted-by":"crossref","unstructured":"Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol\u20081992; 23: 117\u201328.","DOI":"10.1016\/0046-8177(92)90232-R"},{"key":"2022061700304227500_B19","doi-asserted-by":"crossref","unstructured":"de Boer MA, Jordanova ES, Kenter GG, et al. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res\u20082007; 13: 132\u20138.","DOI":"10.1158\/1078-0432.CCR-06-1568"},{"key":"2022061700304227500_B20","doi-asserted-by":"crossref","unstructured":"Rosty C, Sheffer M, Tsafrir D, et al. Identification of a proliferation gene cluster associated with HPV E6\/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene\u20082005; 24: 7094\u2013104.","DOI":"10.1038\/sj.onc.1208854"},{"key":"2022061700304227500_B21","doi-asserted-by":"crossref","unstructured":"Ha\u0308fner N, Driesch C, Gajda M, et al. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene. Epub 2007 Sep 10.","DOI":"10.1038\/sj.onc.1210791"},{"key":"2022061700304227500_B22","doi-asserted-by":"crossref","unstructured":"Yu T, Ferber MJ, Cheung TH, Chung TK, Wong YF, Smith DI. The role of viral integration in the development of cervical cancer. Cancer Genet Cytogenet\u20082005; 158: 27\u201334.","DOI":"10.1016\/j.cancergencyto.2004.08.021"},{"key":"2022061700304227500_B23","unstructured":"Koopman LA, Szuhai K, van Eendenburg JD, et al. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer Res\u20081999; 59: 5615\u201324."},{"key":"2022061700304227500_B24","doi-asserted-by":"crossref","unstructured":"Thorland EC, Myers SL, Gostout BS, Smith DI. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene\u20082003; 22: 1225\u201337.","DOI":"10.1038\/sj.onc.1206170"},{"key":"2022061700304227500_B25","doi-asserted-by":"crossref","unstructured":"Ziegert C, Wentzensen N, Vinokurova S, et al. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene\u20082003; 22: 3977\u201384.","DOI":"10.1038\/sj.onc.1206629"},{"key":"2022061700304227500_B26","doi-asserted-by":"crossref","unstructured":"Reuter S, Bartelmann M, Vogt M, et al. APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB\/POZ-zinc finger protein with growth inhibitory activity. EMBO J\u20081998; 17: 215\u201322.","DOI":"10.1093\/emboj\/17.1.215"},{"key":"2022061700304227500_B27","doi-asserted-by":"crossref","unstructured":"Du\u0308rst M, Croce CM, Gissmann L, Schwarz E, Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A\u20081987; 84: 1070\u20134.","DOI":"10.1073\/pnas.84.4.1070"},{"key":"2022061700304227500_B28","doi-asserted-by":"crossref","unstructured":"Ferber MJ, Thorland EC, Brink AA, et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene\u20082003; 22: 7233\u201342.","DOI":"10.1038\/sj.onc.1207006"},{"key":"2022061700304227500_B29","doi-asserted-by":"crossref","unstructured":"Ferber MJ, Montoya DP, Yu C, et al. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene\u20082003; 22: 3813\u201320.","DOI":"10.1038\/sj.onc.1206528"},{"key":"2022061700304227500_B30","doi-asserted-by":"crossref","unstructured":"Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+\/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol\u20081997; 35: 791\u20135.","DOI":"10.1128\/jcm.35.3.791-795.1997"},{"key":"2022061700304227500_B31","doi-asserted-by":"crossref","unstructured":"Kraus I, Molden T, Erno LE, Skomedal H, Karlsen F, Hagmar B. Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones. Br J Cancer\u20082004; 90: 1407\u201313.","DOI":"10.1038\/sj.bjc.6601691"},{"key":"2022061700304227500_B32","doi-asserted-by":"crossref","unstructured":"Frohman MA. Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE. Methods Enzymol\u20081993; 218: 340\u201356.","DOI":"10.1016\/0076-6879(93)18026-9"},{"key":"2022061700304227500_B33","doi-asserted-by":"crossref","unstructured":"Ha\u0308fner N, Gajda M, Altgassen C, et al. HPV16\u20136 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR. Int J Cancer\u20082007; 120: 1842\u20136.","DOI":"10.1002\/ijc.22521"},{"key":"2022061700304227500_B34","unstructured":"Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res\u20081999; 59: 6132\u20136."},{"key":"2022061700304227500_B35","doi-asserted-by":"crossref","unstructured":"Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol\u20081990; 215: 403\u201310.","DOI":"10.1016\/S0022-2836(05)80360-2"},{"key":"2022061700304227500_B36","doi-asserted-by":"crossref","unstructured":"Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res\u20082002; 12: 996\u20131006.","DOI":"10.1101\/gr.229102"},{"key":"2022061700304227500_B37","doi-asserted-by":"crossref","unstructured":"Furey TS, Haussler D. Integration of the cytogenetic map with the draft human genome sequence. Hum Mol Genet\u20082003; 12: 1037\u201344.","DOI":"10.1093\/hmg\/ddg113"},{"key":"2022061700304227500_B38","doi-asserted-by":"crossref","unstructured":"Carmody MW, Jones M, Tarraza H, Vary CP. Use of the polymerase chain reaction to specifically amplify integrated HPV-16 DNA by virtue of its linkage to interspersed repetitive DNA. Mol Cell Probes\u20081996; 10: 107\u201316.","DOI":"10.1006\/mcpr.1996.0015"},{"key":"2022061700304227500_B39","unstructured":"Thorland EC, Myers SL, Persing DH, et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res\u20082000; 60: 5916\u201321."},{"key":"2022061700304227500_B40","doi-asserted-by":"crossref","unstructured":"Luft F, Klaes R, Nees M, et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer\u20082001; 92: 9\u201317.","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L"},{"key":"2022061700304227500_B41","doi-asserted-by":"crossref","unstructured":"Kalantari M, Blennow E, Hagmar B, Johansson B. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol\u20082001; 10: 46\u201354.","DOI":"10.1097\/00019606-200103000-00008"},{"key":"2022061700304227500_B42","unstructured":"Van Tine BA, Knops J, Broker TR, Chow LT, Moen PT, Jr. In situ analysis of the transcriptional activity of integrated viral DNA using tyramide-FISH. Dev Biol (Basel)\u20082001; 106: 381\u20135."},{"key":"2022061700304227500_B43","doi-asserted-by":"crossref","unstructured":"Cannizzaro LA, Du\u0308rst M, Mendez MJ, Hecht BK, Hecht F. Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet Cytogenet\u20081988; 33: 93\u20138.","DOI":"10.1016\/0165-4608(88)90054-4"},{"key":"2022061700304227500_B44","unstructured":"Popescu NC, DiPaolo JA. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res\u20081990; 50: 1316\u201323."},{"key":"2022061700304227500_B45","doi-asserted-by":"crossref","unstructured":"Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, von Knebel Doeberitz M. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene\u20082002; 21: 419\u201326.","DOI":"10.1038\/sj.onc.1205104"},{"key":"2022061700304227500_B46","doi-asserted-by":"crossref","unstructured":"Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre-Garau X. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene\u20082006; 25: 5985\u201393.","DOI":"10.1038\/sj.onc.1209625"},{"key":"2022061700304227500_B47","doi-asserted-by":"crossref","unstructured":"Shera KA, Shera CA, McDougall JK. Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J Virol\u20082001; 75: 12339\u201346.","DOI":"10.1128\/JVI.75.24.12339-12346.2001"},{"key":"2022061700304227500_B48","doi-asserted-by":"crossref","unstructured":"Liu CX, Li Y, Obermoeller-McCormick LM, Schwartz AL, Bu G. The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein. J Biol Chem\u20082001; 276: 28889\u201396.","DOI":"10.1074\/jbc.M102727200"},{"key":"2022061700304227500_B49","doi-asserted-by":"crossref","unstructured":"Langbein S, Szakacs O, Wilhelm M, et al. Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest\u20082002; 82: 639\u201343.","DOI":"10.1038\/labinvest.3780458"},{"key":"2022061700304227500_B50","doi-asserted-by":"crossref","unstructured":"Liu CX, Musco S, Lisitsina NM, Yaklichkin SY, Lisitsyn NA. Genomic organization of a new candidate tumor suppressor gene, LRP1B. Genomics\u20082000; 69: 271\u20134.","DOI":"10.1006\/geno.2000.6331"},{"key":"2022061700304227500_B51","doi-asserted-by":"crossref","unstructured":"Sonoda I, Imoto I, Inoue J, et al. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res\u20082004; 64: 3741\u20137.","DOI":"10.1158\/0008-5472.CAN-04-0172"},{"key":"2022061700304227500_B52","doi-asserted-by":"crossref","unstructured":"Schwartz M, Zlotorynski E, Kerem B. The molecular basis of common and rare fragile sites. Cancer Lett\u20082006; 232: 13\u201326.","DOI":"10.1016\/j.canlet.2005.07.039"},{"key":"2022061700304227500_B53","doi-asserted-by":"crossref","unstructured":"Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet\u20081996; 5: 187\u201395.","DOI":"10.1093\/hmg\/5.2.187"},{"key":"2022061700304227500_B54","doi-asserted-by":"crossref","unstructured":"Shabalina SA, Spiridonov NA. The mammalian transcriptome and the function of non-coding DNA sequences. Genome Biol\u20082004; 5: 105.","DOI":"10.1186\/gb-2004-5-4-105"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/7\/2514\/2593956\/2514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/7\/2514\/2593956\/2514.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:44:40Z","timestamp":1655444680000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/7\/2514\/540874\/The-Majority-of-Viral-Cellular-Fusion-Transcripts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,4,1]]},"published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-2776","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}